Mainly on INCY, but is a response to:
siliconinvestor.com
--------------Biotech | Derivatives
To: Doc Bones who wrote (393)
From: PeterSuzman Wednesday, Sep 15 1999 2:41PM ET
Respond to Post # 394 of 418
"NASDAQ - Stdnger ldgre, rekyl pe fredagens uppgeng"
Ah, that explains everything then - at least for those of us lucky enough to know the code. <g>
Peter
---------------------
Of course "they" will not give me access to the code: "they" are plotting against me. So I must analyze it using only plain English. No sweat.
The only valid English word, as your spell checker can tell you, is "pe", "p" in the Hebrew alphabet. What can "pe" mean in the context of an INCY headline? Only PE Bio: Perkin Elmer, aka Celera, which somehow manages to hide INCY under a dark cloud. See the Yahoo post below for the latest.
I read an article a few months ago in some reputable(?) publication that I have never been able to find a trace of in internet searches. They essentially implied that INCY was plotting to destroy the human race, because they had mapped the drug-resistant (including Vancomycin} staph bacteria, and would not give it away for free to everyone.
I felt that INCY had risked a lot of money to do this kind of thing, and shared their info with many customers, unlike others. It seemed a bit much that a small biotech teetering along financially, which had done the advanced research, should have to give it away for free to a fabulously wealthy medical establishment, but I may be prejudiced. (Though this was before my INCY purchase.)
I think mainly the academic Human Genome project was grouching, and using it as an excuse to accelerate funding and schedule big time. But Celera was also criticizing and belittling INCYs methods, in the person of leader Craig Ventner. Now Craig is a modest guy just trying to keep his name out of the papers, ("I'm not really the super-genius everyone says I am") but who somehow pops up everywhere.
Here's Craig announcing that he'll be constructing a living organism from basic parts, apparently the first to do so since God The Father. He was forced to go public with this because we must have a debate about it first.
gene.ch
There are numerous articles extolling Celera's methods in the New York Times, MIT's Technology magazine, etc., though the superiority of their methods seems at least subject to debate.
Did anyone else see the INCY destroys the human race article? Or could "they" be using the secret code to directly program my brain??
Doc
****************
messages.yahoo.com
--------------------------------------------------------------------------------
Posted: 9/22/1999 5:24 pm EDT as a reply to: Msg 1536 by siliconmaestro
Even the Yahoo press Biased against us.
by: biomed_dude 1533 of 1545
Check out this news interview with INCYTE President R. Scott but the reporter never put INCY stock ticker so the PR went to CRA This is really amazing we can not even get some press on this stock. Any ideas how we can get them to fix this..prevent future stuff. may be Randy should make sure when he gets interviewed to assure the gives the INCY ticker to the reporter but then again does he care about the share holders?!! or just his salary..We need some PR Savvy management at incyte, look at CRA, Affx, etc..
dailynews.yahoo.com
--------------------------------------------------------------------------------
Posted: 9/21/1999 8:35 pm EDT as a reply to: Msg 1532 by biomed_dude
Yahoo! News Science Headlines
Tuesday September 21 6:34 PM ET
We Have More Genes Than We Thought - U.S. Company
By Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - Human beings may have twice as many genes as previously thought, researchers at a biotechnology company said Tuesday -- a suggestion that would have big implications for scientists racing to map all the genes.
Palo Alto, California-based Incyte Pharmaceuticals, Inc. says it estimates humans have 140,000 genes. The company says it has sequenced most of these genes, and has added what it has found to publicly available data on genes to come up with the figure.
``Most recent estimates are between 60,000 to 80,000 genes,' Randy Scott, chief executive officer and chief scientific officer for Incyte said in a telephone interview.
``Our data confirms there are 140,000 or so -- so we are almost twice what those last estimates were.'
<snip> |
